SALT LAKE CITY, January 28, 2016- Clinical Innovations, a member of Pritzker Group Private Capital’s family of companies and the largest healthcare manufacturer exclusively focused on labor and delivery, today announced the promotion of Ross McQuivey, M.D., from medical director to chief medical officer.
McQuivey originally joined Clinical Innovations in 2003, providing leadership in medical affairs and intelligence, clinical program development and medical safety and risk assessments. In his expanded role, McQuivey will also be responsible for supporting business acquisitions, new product innovation, advisory board oversight, product quality evaluations and clinical affairs.
McQuivey serves as an adjunct clinical instructor within the department of obstetrics and gynecology at the Stanford University School of Medicine and has provided more than 150 international lectures and more than 200 domestic workshops advancing medical intelligence and training. He holds a bachelor’s degree in psychology from Stanford University and a doctorate of medicine from the University of Utah School of Medicine.
“Ross brings nearly two decades of exemplary scientific, medical and business leadership in the medical device industry, with documented success developing creative and innovative solutions to thrive in untapped and highly competitive markets,” said Ken Reali, president and CEO of Clinical Innovations. “He’s been instrumental in developing the culture and growth strategy at Clinical Innovations and we’re proud of his continued role on our senior leadership team.”
“I’m honored and humbled to serve with such dedicated, visionary colleagues, like Ken, who work tirelessly to improve care and outcomes for patients and families,” said McQuivey. “Never has there been a more transformative time in healthcare and I look forward to continuing to set the standard for excellence with the world-class Clinical Innovations team.”
McQuivey and other Clinical Innovations executives will be participating in the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy Meeting™ in Atlanta beginning Feb. 1. The conference draws more than 2,000 international maternal-fetal medicine specialists.
Clinical Innovations will also host a booth during the meeting’s exhibit days from Feb. 3–5, highlighting recent additions to the company’s innovative product portfolio.
About Clinical Innovations
Clinical Innovations is the largest healthcare manufacturer exclusively focused on labor and delivery. Already a market leader in several categories with products such as the Koala® Intrauterine Pressure Catheter and Kiwi® Vacuum-Assisted Delivery System, Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is a Pritzker Group company. For more information, visit clinicalinnovations.com.
Pritzker Group, led by Tony and J.B. Pritzker, has three principal investment teams: Private Capital, which acquires and operates leading North America-based companies; Venture Capital, which provides early-stage and growth venture funding to technology companies throughout the United States; and Asset Management, which partners with top-performing investment managers across global public markets.
Pritzker Group Private Capital acquires North America-based middle-market companies with leading positions in the manufactured products, services and healthcare sectors. The firm’s permanent, proprietary capital base allows for efficient decision making, broad flexibility with transaction structure and investment horizon, and alignment with management teams focused on creating long-term value. Pritzker Group brings significant resources, expertise and credibility in building businesses and is an ideal partner for entrepreneur- and family-owned companies. For more information, visit pritzkergroup.com.